Navigation Links
Resynchronization in Medical News

Heart Rhythm Society Introduced to New Method for Optimizing Cardiac Resynchronization Therapy During Exercise

Heart Rhythm Society Introduced to New Method for Optimizing Cardiac Resynchronization Therapy During Exercise. The new FDA-approved Shape-HF™ Cardiopulmonary Testing System "can make a dramatic difference in treating CRT patients." Dr. Abraham Kocheril, Professor of Medicine and ...

Boston Scientific Announces CE Mark Approval for Next-Generation Cardiac Resynchronization Therapy Defibrillator

NATICK, Mass., Dec. 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark approval for its LIVIAN(TM) cardiac resynchronization therapy defibrillator (CRT-D), which treats heart failure and helps protect patients at risk of sudden cardiac death. The L...

Study puts brakes on extending indications for cardiac resynchronization therapy

A randomized, controlled, multi-center trial has found that cardiac resynchronization therapy produced no improvement in peak oxygen uptake during exercise testing, the trial's primary endpoint, in patients with Class III heart failure, including mechanical problems that disrupt the heart's normal...

University of Zurich Announces Worldwide Clinical Trial of Cardiac Resynchronization Therapy

The University of Zurich announces an investigator initiated large-scale prospective randomized controlled clinical trial to assess the clinical impact of Cardiac Resynchronization Therapy (CRT) in heart failure patients. The worldwide study, called "Echocardiography guided Cardiac Resync...

EUROPACE raises remote monitoring profile

...). Cardiovascular implantable electronic devices (CIEDs) - which include cardiac pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy (CRT) devices, implantable cardiovascular monitors and implantable loop recorders - have now been developed with numerous programmable feature...

New Shape-HF™ Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting

...he individual patient and track patient progress. In addition, using the Shape-HF™ to measure changes in patient breathing efficiency as cardiac resynchronization therapy (CRT) settings are adjusted allows physicians to assess the physiological effect of therapy in real time while the patient is exercising at a ...

Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process

...) 4-SITE defibrillation lead system. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) to the heart and, when needed, deliver life-saving therapy. The ENDOTAK RELIANCE 4-SITE lead system is designed t...

Patients Call for Continued FDA Preemption Authority

... "Without my medical device, I would not be here today," said Laura Doud of Arlington, Virginia, who received life-saving implantation of cardiac resynchronization therapy with defibrillation in 2004 after suffering almost fatal viral cardiomyopathy. "If the proposed legislation were passed, would the lawsuits fa...

Cardiac Patients Take NASA Super Plastic to Heart

...xygen. It is a chronic and progressive condition that affects more than five million Americans and more than 22 million individuals worldwide. Cardiac resynchronization therapy, or CRT, is designed to coordinate the contraction of the heart's two lower chambers and improve the heart's efficiency to increase blood flow...

Doctor's Training Affects Defibrillator Implant Results

...iologists," Curtis said. Another marked difference found in the study concerned people who require an implanted defibrillator that provides cardiac resynchronization therapy (CRT-D). "These are patients with heart failure, in which the heart is not only weak and inefficient but also beats in a disorganized way," Cu...
Resynchronization in Medical Technology

New Therapy Found to Prevent Heart Failure

...th heart disease who received an implanted cardiac resynchronization therapy device with defibrillator (CRT-D) versus p...atic Defibrillator Implantation Trial with Cardiac resynchronization Therapy) is a clinical trial that enrolled more th...s and heart failure. The new generation of cardiac resynchronization therapy defibrillators (CRT-Ds) was designed to st...

MADIT-CRT Trial Meets Primary Endpoint

...t its primary endpoint. Preliminary results show Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) to be associated with a significant 29 perc...ely by Boston Scientific, demonstrates that early intervention with cardiac resynchronization therapy can slow the progression of heart failure. It is the world's large...

Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials

...the LATITUDE(R) Patient Management system. Five-year survival rate data for patients using implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) were presented at the Heart Rhythm Society Scientific Sessions in Boston by Leslie Saxon, M.D., F.A.C.C., Chief, Cardi...

First Swiss Patients Treated with the Percutaneous MitraClip(R) System

...art failure is a devastating disease, significantly more common than cancer and has the same poor life-expectancy. Implantable devices such as cardiac resynchronization therapy have improved the quality of life of these patients. Now with percutaneous mitral valve repair, I am confident we can expand our treatment pos...

Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death

...TICK, Mass., Jan. 22 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark approval for its COGNIS(TM) cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN(TM) implantable cardioverter defibrillator (ICD). These devices represent entirely new platforms to treat he...
Resynchronization in Medical Products

Kronos LV-T Cardiac Resynchronization Therapy Defibrillator (CRT-D) System

Description: RV Tracking for 100 % Resynchronization...
Company:Biotronik GmbH & Co.

InSync III Cardiac Resynchronization System

Description: The Medtronic InSync III Model 8042 increases therapy versatility with faster programming, and the ability to optimize sensing, pacing and cardiac output. The InSync III system also offers unmatched insight through key heart failure diagnostics and monitoring trends, to efficiently track a patient'...
Company:Medtronic Inc.

Frontier CRT-P

Description:...-port (one atrial and two ventricular) multi-chamber device capable of stimulating the heart in a biventricular or left-ventricular fashion to promote resynchronization and improved hemodynamic performance in patients with heart failure....
Company:St. Jude Medical, Inc.

Insync Sentry™

Description:... InSync Sentry cardiac resynchronization therapy (CRT) defibrillator system. It is the worlds first implantable medical therapy offering automatic fluid status monitoring in the thoracic cavi...
Company:Medtronic Vascular

Attain OTW Model 4194 Bi-Polar

Description:...e Attain 4194 Bipolar over-the-wire left-heart lead is for use with cardiac resynchronization systems. This new steroid-eluting lead has an angled shape and can be inser...ft-heart leads designed for use with the Medtronic InSync family of cardiac resynchronization therapy (CRT) pacemaker and defibrillator systems....
Company:Medtronic Inc.

Atlas® + HF ICD

Description:... the best in patient safety, programming flexibility, comfort, and quality of life. The Atlas+ HF ICD is the worlds most powerful ICD offering cardiac resynchronization therapy (CRT), and it packs its power into a compact, 81 gram and 40 cc physiologic-shaped can. In addition to its high energy, the device offers high...
Company:St. Jude Medical, Inc.

Epic™ HF ICD

Description:...ld's smallest and lightest 30 joule (delivered energy) biventricular ICD. Small size doesn't mean sacrifice, though. The Epic HF ICD features advanced resynchronization parameters along with 34 joules stored/30 joules delivered energy and a 7.5 second charge time....
Company:St. Jude Medical, Inc.

Tupos LV/A+

Description:... With the Tupos LV/A+, the single-lead principle has been applied to cardiac resynchronization therapy for the first time. The complete system, which consists of the Tupos LV/A+ and the five-polar Kainox A+ lead, minimizes the scope of surgery a...
Company:Biotronik GmbH & Co.

InSync ICD

Description:... The Medtronic InSync ICD cardiac resynchronization and ICD device offers 34 Joule therapy in 7 seconds (BOL). The unit's RV only sensing provides no opportunity for double counting of RV and LV depolar...
Company:Medtronic Inc.

Contak® Renewal™ 3

Description:... The Guidant Contak Renewal 3 cardiac resynchronization therapy defibrillator provides ventricular tachyarrhythmia therapy and cardiac resynchronization therapy. Features: Independently programmable right ventricular (RV) and le...
Company:Guidant Corporation
Resynchronization in Medical Dictionary

Cardiac Failure

...in which the heart can no longer pump enough blood to ... Cardiac resynchronization therapy - CRT - for heart failure ... Cardiac resynchronization therapy - CRT. This new heart failure treatment also reduces mortalit...
Resynchronization in Biological News

Syntermed licenses Emory ERTb software for enhanced cardiac imaging

...n, including the recent FDA cleared SyncTool™, which is designed to more accurately select heart failure patients who would benefit from cardiac resynchronization therapy (CRT). Garcia is the scientific founder and chief scientific advisor of Syntermed. The company is co-owned in part by Emory and Georgia Tech...

Implanted Devices Detect High-Risk Heart Failure Patients

...e, according to researchers at Duke University Medical Center. Besides maintaining optimal electrical stimulation to the heart, these CRT-D (cardiac resynchronization therapy with defibrillation) devices are giving cardiologists a new view of subtle changes in a key measurement of heart health -- heart rate variabil...
Resynchronization in Biological Technology

Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System

...ersion of the LATITUDE system is compatible with the Company's wireless TELIGEN(R) implantable cardioverter defibrillator (ICD) and COGNIS(R) cardiac resynchronization therapy defibrillator (CRT-D), the world's smallest and thinnest high-energy devices. The first enrollments of European patients onto the LA...

Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients

...ounced that it has agreed to donate Cardiac Rhythm Management (CRM) devices, including pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices to Heartbeat International, a non-profit organization dedicated to providing CRM devices and medical care at no charge to needy patien...

Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions

...and the ALTITUDE Clinical Science Program. These presentations will provide new insights for implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) patients. Schedule of Events (all times are Eastern Time) Tuesday, May 12 Cardiac Rhythm Man...

University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF™ Cardiopulmonary Testing System

...tems. This makes it possible for the physician to evaluate therapy options for the individual patient and track patient progress. In addition, cardiac resynchronization therapy (CRT) has become a mainstay in treating patients with severe heart failure when alternative treatment options have been exhausted. According t...

Boston Scientific Announces FDA Approval of New Heart Failure Lead

...tion (NYSE: BSX ) today announced U.S. Food and Drug Administration (FDA) approval of its ACUITY(R) Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators (CRT-D) and cardiac resynchronization therapy pacemakers (CRT-P), both of which treat heart failure. The ACUITY Spiral lead is ...

Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data

...e initiative will use the substantial LATITUDE data to seek answers to common questions related to implantable cardiac defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) device therapy. The ALTITUDE initiative will be managed in collaboration with an external physician panel of thought lea...

Boston Scientific Announces Japanese Approval of Heart Failure Lead

...) today announced Japanese Ministry of Health, Labor and Welfare (MHLW) approval of its ACUITY(R) Steerable left ventricular lead for use with cardiac resynchronization therapy (CRT) devices, which treat heart failure. The Company also received reimbursement approval for the lead from the National Health Insurance Sys...

Boston Scientific Announces European Approval of New Heart Failure Lead

... Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, both of which treat heart fail... factor in providing patients with optimal cardiac resynchronization therapy," said Fred Colen, Executive Vice Presiden...

Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business

...otect patients at risk of sudden cardiac death -- The LIVIAN(TM) cardiac resynchronization therapy defibrillator (CRT-D), which provides cardiac resynchronization and defibrillation therapies in one device -- An upgraded LATITUDE(...

Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer

...ne as an Electrophysiologist at the Cleveland Clinic. His specialties include remote navigation, new technology assessment and optimization of Cardiac resynchronization Therapy. In 2005, he was appointed Associate Program Director at the Cleveland Clinic. He has authored or co-authored over 30 peer-reviewed publicatio...
Other Tags
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... Four years since the release of their debut recording Love ... of Avasa & Matthew Love – the duo are pleased to ... through White Swan Records on February 24, 2015. , THE ROAD ... available to all of us to walk out of the mire ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 As interest in ... health care gains momentum worldwide, Rev. Eric J. Hall ... Chaplaincy Network (HCCN), will be the keynote speaker on ... in Israel’s public health system. , The conference, “Hope and ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the importance of ... the costs of an auto insurance policy . , Clients ... prices for their vehicle insurance policies. The safety a vehicle offers ... Because of this, drivers should always carry a first aid ...
(Date:12/26/2014)... The US represents the largest market for CRC across the ... that sales of branded therapies were $2.23 billion. The US ... of the disease, high drug treatment rate, and higher drug ... of CRC therapies over the forecast period will be driven ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
(Date:1/22/2015)... Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), ... crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz ... production capacity to meet customer demand. ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by ...
(Date:1/22/2015)... 16, 2015  A man-made form of insulin delivered by ... capabilities in adults with mild cognitive impairment and Alzheimer,s ... researchers at Wake Forest Baptist Medical Center. ... mild cognitive impairment (MCI) or mild to moderate Alzheimer,s ...
(Date:1/22/2015)... , Jan. 21, 2015  Analyst Report Issued by Small ... Brands report showed that planet-wide, transactions at merchants on the ... the total number of credit, debit, and prepaid cards reached ... were victims of fraudulent card usage in 2012, and credit ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
Other Contents